150 related articles for article (PubMed ID: 30924126)
21. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
Kawamura Y; Nakaoka H; Nakayama A; Okada Y; Yamamoto K; Higashino T; Sakiyama M; Shimizu T; Ooyama H; Ooyama K; Nagase M; Hidaka Y; Shirahama Y; Hosomichi K; Nishida Y; Shimoshikiryo I; Hishida A; Katsuura-Kamano S; Shimizu S; Kawaguchi M; Uemura H; Ibusuki R; Hara M; Naito M; Takao M; Nakajima M; Iwasawa S; Nakashima H; Ohnaka K; Nakamura T; Stiburkova B; Merriman TR; Nakatochi M; Ichihara S; Yokota M; Takada T; Saitoh T; Kamatani Y; Takahashi A; Arisawa K; Takezaki T; Tanaka K; Wakai K; Kubo M; Hosoya T; Ichida K; Inoue I; Shinomiya N; Matsuo H
Ann Rheum Dis; 2019 Oct; 78(10):1430-1437. PubMed ID: 31289104
[TBL] [Abstract][Full Text] [Related]
22. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals.
Hoey BM; Butler J; Halliwell B
Free Radic Res Commun; 1988; 4(4):259-63. PubMed ID: 2852627
[TBL] [Abstract][Full Text] [Related]
23. Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes.
Szabó E; Kulin A; Mózner O; Korányi L; Literáti-Nagy B; Vitai M; Cserepes J; Sarkadi B; Várady G
PLoS One; 2021; 16(12):e0260957. PubMed ID: 34855903
[TBL] [Abstract][Full Text] [Related]
24. Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population.
Cheng ST; Wu S; Su CW; Teng MS; Hsu LA; Ko YL
J Formos Med Assoc; 2017 Jan; 116(1):18-23. PubMed ID: 26792383
[TBL] [Abstract][Full Text] [Related]
25. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
26. No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.
Stamp LK; Topless R; Miner JN; Dalbeth N; Merriman T
Rheumatology (Oxford); 2019 Mar; 58(3):547-548. PubMed ID: 30597115
[No Abstract] [Full Text] [Related]
27. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol.
Ko KM; Godin DV
Biochem Pharmacol; 1990 Aug; 40(4):803-9. PubMed ID: 2117456
[TBL] [Abstract][Full Text] [Related]
28. Renal clearances of purine bases and oxypurinol during glucose infusion.
Moriwaki Y; Yamamoto T; Takahashi S; Nasako Y; Hada T; Higashino K
Adv Exp Med Biol; 1994; 370():39-42. PubMed ID: 7660935
[No Abstract] [Full Text] [Related]
29. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
[TBL] [Abstract][Full Text] [Related]
31. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
32. The effects of allopurinol, uric acid, and inosine administration on xanthine oxidoreductase activity and uric acid concentrations in broilers.
Settle T; Carro MD; Falkenstein E; Radke W; Klandorf H
Poult Sci; 2012 Nov; 91(11):2895-903. PubMed ID: 23091148
[TBL] [Abstract][Full Text] [Related]
33. ABCG2/BCRP dysfunction as a major cause of gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
[TBL] [Abstract][Full Text] [Related]
35. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
36. Optimizing therapy with allopurinol: factors limiting hypouricemic efficacy.
Chung Y; Stocker SL; Graham GG; Day RO
Am J Med Sci; 2008 Mar; 335(3):219-26. PubMed ID: 18344696
[TBL] [Abstract][Full Text] [Related]
37. Effect of allopurinol on caffeine disposition in man.
Grant DM; Tang BK; Campbell ME; Kalow W
Br J Clin Pharmacol; 1986 Apr; 21(4):454-8. PubMed ID: 3754760
[TBL] [Abstract][Full Text] [Related]
38. Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.
Giri AK; Banerjee P; Chakraborty S; Kauser Y; Undru A; Roy S; Parekatt V; Ghosh S; Tandon N; Bharadwaj D
Sci Rep; 2016 Feb; 6():21440. PubMed ID: 26902266
[TBL] [Abstract][Full Text] [Related]
39. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
Fuchs P; Haefeli WE; Ledermann HR; Wenk M
Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
[TBL] [Abstract][Full Text] [Related]
40. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells.
Komori H; Yamada K; Tamai I
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):973-980. PubMed ID: 29317200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
